Carli Lehr is a transplant pulmonologist and health services researcher whose work is focused on access to transplant and organ allocation. She completed medical school at The Ohio State University, internal medicine residency at Duke University, pulmonary and critical care fellowship training at Cleveland Clinic, and earned her doctoral degree in Clinical Translational Science from Case Western Reserve University.
Dr. Lehr has been an active member of the AST since 2017 and has contributed to society initiatives including those focused on patient advocacy, trainee engagement, and guideline development. She has served on the executive committee of the Thoracic and Critical Care Community of Practice, where she helped develop a formal mentorship program for trainees and early-career transplant professionals. Her commitment to mentorship extended to the Trainee and Young Faculty Community of Practice, where she later served as Chair. In this role, she worked to expand opportunities for engagement in AST, including the development of a structured transdisciplinary mentorship program and focused travel grant opportunities for trainees. Dr. Lehr has additionally participated in special interest task forces focused on reimagining the structure of AST meetings and establishing a pathway for the development of AST standards and guidelines. Since joining the Community Education Committee in 2021, she has served as Chair, leading initiatives to develop patient-focused educational resources and collaborating with the patient-led Transplant Community Advisory Council on efforts to advance public understanding of transplantation and organ donation.
Outside of the AST, Dr. Lehr has developed a in-depth understanding of national transplant trends through her work co-authoring the Lung Annual Data Report since 2016 and serving on the Scientific Registry of Transplant Recipients Scientific Review Committee since 2023, which she now Co-Chairs. Dr. Lehr additionally leads the International Society for Heart and Lung Transplantation’s Advanced Lung Failure and Transplantation Interdisciplinary Network, where she works to foster collaboration across disciplines, connect clinicians and scientists, and advance shared solutions to complex challenges in advanced lung disease and transplantation. Dr. Lehr’s NIH- and Cystic Fibrosis Foundation–funded research has contributed to understanding of national lung allocation changes associated with the transition to continuous distribution and their implications for transplant policy.
Dr. Lehr’s work reflects her commitment to improving the lives of transplant patients by advancing equitable access to transplantation and organ allocation and strengthening systems that support transplant care.
Advertisements
